[
  {
    "ts": null,
    "headline": "Labcorp Holdings Inc. stock outperforms competitors despite losses on the day",
    "summary": "Labcorp Holdings Inc. stock outperforms competitors despite losses on the day",
    "url": "https://finnhub.io/api/news?id=90d5571028ddb74a5362fbf36523da62857bbc0d9eccb8fe591494bc0bdcd565",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1750179900,
      "headline": "Labcorp Holdings Inc. stock outperforms competitors despite losses on the day",
      "id": 135368016,
      "image": "",
      "related": "LH",
      "source": "MarketWatch",
      "summary": "Labcorp Holdings Inc. stock outperforms competitors despite losses on the day",
      "url": "https://finnhub.io/api/news?id=90d5571028ddb74a5362fbf36523da62857bbc0d9eccb8fe591494bc0bdcd565"
    }
  },
  {
    "ts": null,
    "headline": "False Start: U.S. Supreme Court Declines To Decide Whether Courts May Certify Damages Classes That Include Uninjured Class Members",
    "summary": "Seyfarth Synopsis: On June 5, 2025, the U.S. Supreme Court changed course and dismissed the writ of certiorari that it previously had granted in Laboratory Corporation of America Holdings v. Davis,...",
    "url": "https://finnhub.io/api/news?id=e22dbf9a4e7d08fb36445f92a1a774765b5166e08ec72305207cca9d28479bed",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1750147874,
      "headline": "False Start: U.S. Supreme Court Declines To Decide Whether Courts May Certify Damages Classes That Include Uninjured Class Members",
      "id": 135325961,
      "image": "",
      "related": "LH",
      "source": "Finnhub",
      "summary": "Seyfarth Synopsis: On June 5, 2025, the U.S. Supreme Court changed course and dismissed the writ of certiorari that it previously had granted in Laboratory Corporation of America Holdings v. Davis,...",
      "url": "https://finnhub.io/api/news?id=e22dbf9a4e7d08fb36445f92a1a774765b5166e08ec72305207cca9d28479bed"
    }
  },
  {
    "ts": null,
    "headline": "Morgan Stanley Hikes Labcorp (LH) Holdings Price Target to $283 Affirms ‘Overweight’ Rating",
    "summary": "Laboratory Corporation of America Holdings (NYSE:LH) is one of the best healthcare stocks to buy now. On June 11, Morgan Stanley reiterated the stock’s ‘Overweight’ rating and raised the 12-month price target to $283 from $270. The adjustment underscores the investment firm’s confidence in the company’s growth prospects as it also faces durable demand for […]",
    "url": "https://finnhub.io/api/news?id=cbf23505f51a05759cbaad567e3b64b8ef7e4e4681d9423323e5eee30bb66703",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1750141457,
      "headline": "Morgan Stanley Hikes Labcorp (LH) Holdings Price Target to $283 Affirms ‘Overweight’ Rating",
      "id": 135318417,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "LH",
      "source": "Yahoo",
      "summary": "Laboratory Corporation of America Holdings (NYSE:LH) is one of the best healthcare stocks to buy now. On June 11, Morgan Stanley reiterated the stock’s ‘Overweight’ rating and raised the 12-month price target to $283 from $270. The adjustment underscores the investment firm’s confidence in the company’s growth prospects as it also faces durable demand for […]",
      "url": "https://finnhub.io/api/news?id=cbf23505f51a05759cbaad567e3b64b8ef7e4e4681d9423323e5eee30bb66703"
    }
  }
]